Zymosan-mediated inflammation impairs in vivo reverse cholesterol transport

Journal of Lipid Research

Volumn 52, Issue 5, 2011, Pages 951-957

  Malik, Priya ^a,b   Berisha, Stela Z ^a   Santore, Jennifer ^a   Agatisa Boyle, Colin ^a   Brubaker, Gregory ^a   Smith, Jonathan D ^a,b,c  

^a Department of Molecular Medicine ^*  (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cholesterol efflux; High density lipoprotein; Macrophages

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER B11; ABC TRANSPORTER B4; ABC TRANSPORTER G5; ABC TRANSPORTER G8; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; MESSENGER RNA; SERUM AMYLOID A; UNCLASSIFIED DRUG; ZYMOSAN;

ABCB11 GENE; ABCB4 GENE; ABCG5 GENE; ABCG8 GENE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CHOLESTEROL TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE; GENE EXPRESSION; IN VITRO STUDY; INFLAMMATION; LIPID BLOOD LEVEL; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE CHOLESTEROL TRANSPORT;

ANIMALS; CELL LINE; CELLS, CULTURED; CHOLESTEROL; INFLAMMATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; ZYMOSAN;

EID: 79955023084     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M011122     Document Type: Article

References (30)

1. Gordon, T., W. P. Castelli, M. C. Hjortland, W. B. Kannel, and T. R. Dawber. 1977. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am. J. Med. 62 : 707-714. (Pubitemid 8110784)
2. Tall, A. R. 2008. Cholesterol effl ux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins. J. Intern. Med. 263 : 256-273. (Pubitemid 351207349)
3. Rader, D. J., E. T. Alexander, G. L. Weibel, J. Billheimer, and G. H. Rothblat. 2009. The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis. J. Lipid Res. 50 ( Suppl ): S189-S194.
4. Khovidhunkit, W., M. S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld. 2004. Effects of infection and infl ammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host. J. Lipid Res. 45 : 1169-1196. (Pubitemid 38802622)
5. Kontush, A., and M. J. Chapman. 2006. Functionally defective highdensity lipoprotein: A new therapeutic target at the crossroads of dyslipidemia, infl ammation, and atherosclerosis. Pharmacol. Rev. 58 : 342-374. (Pubitemid 44394906)
6. van der Westhuyzen, D. R., F. C. de Beer, and N. R. Webb. 2007. HDL cholesterol transport during infl ammation. Curr. Opin. Lipidol. 18 : 147-151. (Pubitemid 46412084)
7. Zheng, L., B. Nukuna, M. L. Brennan, M. Sun, M. Goormastic, M. Settle, D. Schmitt, X. Fu, L. Thomson, P. L. Fox, et al. 2004. Apolipoprotein A-I is a selective target for myeloperoxidasecatalyzed oxidation and functional impairment in subjects with cardiovascular disease. J. Clin. Invest. 114 : 529-541. (Pubitemid 39572103)
8. Zheng, L., M. Settle, G. Brubaker, D. Schmitt, S. L. Hazen, J. D. Smith, and M. Kinter. 2005. Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol effl ux from macrophages. J. Biol. Chem. 280 : 38-47. (Pubitemid 40164962)
9. Bergt, C., G. Marsche, U. Panzenboeck, J. W. Heinecke, E. Malle, and W. Sattler. 2001. Human neutrophils employ the myeloperoxidase/ hydrogen peroxide/chloride system to oxidatively damage apolipoprotein A-I. Eur. J. Biochem. 268 : 3523-3531. (Pubitemid 32862944)
10. Bergt, C., S. Pennathur, X. Fu, J. Byun, K. O'Brien, T. O. McDonald, P. Singh, G. M. Anantharamaiah, A. Chait, J. Brunzell, et al. 2004. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc. Natl. Acad. Sci. USA. 101 : 13032-13037. (Pubitemid 39167578)
11. Memon, R. A., A. H. Moser, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold. 2001. In vivo and in vitro regulation of sterol 27-hydroxylase in the liver during the acute phase response. potential role of hepatocyte nuclear factor-1. J. Biol. Chem. 276 : 30118-30126.
12. Khovidhunkit, W., A. H. Moser, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold. 2003. Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: Differential role of LXR. J. Lipid Res. 44 : 1728-1736. (Pubitemid 37185884)
13. Hansson, G. K. 2005. Infl ammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352 : 1685-1695.
14. Kaplan, M. J. 2009. Management of cardiovascular disease risk in chronic infl ammatory disorders. Nat. Rev. Rheumatol. 5 : 208-217.
15. McGillicuddy, F. C., M. de la Llera Moya, C. C. Hinkle, M. R. Joshi, E. H. Chiquoine, J. T. Billheimer, G. H. Rothblat, and M. P. Reilly 2009. Infl ammation impairs reverse cholesterol transport in vivo. Circulation. 119 : 1135-1145.
16. Annema, W., N. Nijstad, M. Tolle, J. F. de Boer, R. V. Buijs, P. Heeringa, M. van der Giet, and U. J. Tietge. 2010. Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A2. J. Lipid Res. 51 : 743-754.
17. Zhang, R., M. L. Brennan, Z. Shen, J. C. MacPherson, D. Schmitt, C. E. Molenda, and S. L. Hazen. 2002. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of infl ammation. J. Biol. Chem. 277 : 46116-46122. (Pubitemid 35417600)
18. Di Carlo, F. J., and J. V. Fiore. 1958. On the composition of zymosan. Science. 127 : 756-757.
19. Gantner, B. N., R. M. Simmons, S. J. Canavera, S. Akira, and D. M. Underhill. 2003. Collaborative induction of infl ammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. 197 : 1107-1117. (Pubitemid 36570066)
20. Wang, M. D., V. Franklin, and Y. L. Marcel. 2007. In vivo reverse cholesterol transport from macrophages lacking ABCA1 expression is impaired. Arterioscler. Thromb. Vasc. Biol. 27 : 1837-1842. (Pubitemid 47208488)
21. Smith, J. D., M. Miyata, M. Ginsberg, C. Grigaux, E. Shmookler, and A. S. Plump. 1996. Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol effl ux from a macrophage cell line to apolipoprotein acceptors. J. Biol. Chem. 271 : 30647-30655. (Pubitemid 26404080)
22. Tusher, V. G., R. Tibshirani, and G. Chu. 2001. Signifi cance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA. 98 : 5116-5121. (Pubitemid 32397092)
23. Li, L., P. A. Thompson, and R. L. Kitchens. 2008. Infection induces a positive acute phase apolipoprotein E response from a negative acute phase gene: Role of hepatic LDL receptors. J. Lipid Res. 49 : 1782-1793.
24. van der Westhuyzen, D. R., L. Cai, M. C. de Beer, and F. C. de Beer. 2005. Serum amyloid A promotes cholesterol effl ux mediated by scavenger receptor B-I. J. Biol. Chem. 280 : 35890-35895. (Pubitemid 41633856)
25. Artl, A., G. Marsche, S. Lestavel, W. Sattler, and E. Malle. 2000. Role of serum amyloid A during metabolism of acute-phase HDL by macrophages. Arterioscler. Thromb. Vasc. Biol. 20 : 763-772. (Pubitemid 30151692)
26. Wang, X., H. L. Collins, M. Ranalletta, I. V. Fuki, J. T. Billheimer, G. H. Rothblat, A. R. Tall, and D. J. Rader. 2007. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J. Clin. Invest. 117 : 2216-2224. (Pubitemid 47219566)
27. Baranova, I., T. Vishnyakova, A. Bocharov, Z. Chen, A. T. Remaley, J. Stonik, T. L. Eggerman, and A. P. Patterson. 2002. Lipopolysaccharide down regulates both scavenger receptor B1 and ATP binding cassette transporter A1 in RAW cells. Infect. Immun. 70 : 2995-3003. (Pubitemid 34564159)
28. Castrillo, A., S. B. Joseph, S. A. Vaidya, M. Haberland, A. M. Fogelman, G. Cheng, and P. Tontonoz. 2003. Crosstalk between LCR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol. Cell. 12 : 805-816. (Pubitemid 37352775)
29. Majdalawieh, A., and H-Y. Ro. 2009. LPS-induced suppression of macrophage cholesterol effl ux is mediated by adipocyte enhancerbinding protein 1. Int. J. Biochem. Cell Biol. 41 : 1518-1525.
30. Smoak, K. A., J. J. Aloor, J. Madenspacher, B. A. Merrick, J. B. Collins, X. Zhu, G. Cavigiolio, M. N. Oda, J. S. Parks, and M. B. Fessler. 2010. Myeloid differentiation primary response protein 88 couples reverse cholesterol transport to infl ammation. Cell Metab. 11 : 493-502.